Edition:
United States

Amarantus Bioscience Holdings Inc (AMBS.PK)

AMBS.PK on OTC Markets Group

0.09USD
19 Jan 2018
Change (% chg)

$-0.00 (-3.67%)
Prev Close
$0.09
Open
$0.07
Day's High
$0.09
Day's Low
$0.07
Volume
163,468
Avg. Vol
562,829
52-wk High
$0.21
52-wk Low
$0.01

Latest Key Developments (Source: Significant Developments)

Amarantus Bioscience received orphan drug designation from the US FDA
Wednesday, 10 Feb 2016 07:45am EST 

Amarantus Biosciences Holdings inc:Says it has received orphan drug designation from the US FDA for Eltoprazine in the treatment of Parkinson's disease levodopa-induced dyskinesia (PD-LID).Published positive results from a Phase 2 initial proof-of-concept clinical study in February of 2015 in the journal Brain.  Full Article